Exploring the Potential of N-Palmitoylethanolamide (PEA) in Alzheimer’s Disease Management
Recent research suggests that N-Palmitoylethanolamide (PEA), a naturally occurring fatty acid amide, may play a significant role in alleviating symptoms associated with Alzheimer’s Disease (AD). A preclinical study conducted by scientists from the University of Ferrara, Italy, and published in Frontiers, examined the effects of PEA in animal models of AD.